GEODE CAPITAL MANAGEMENT, LLC - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 69 filers reported holding HARVARD BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 102.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$3,346,079
-15.9%
778,056
+7.4%
0.00%
Q2 2023$3,978,765
+179.4%
724,729
+113.8%
0.00%
Q1 2023$1,423,899
+151539.9%
339,023
+0.0%
0.00%
Q4 2022$939
-99.9%
339,021
+0.8%
0.00%
Q3 2022$861,000
-28.7%
336,373
+0.2%
0.00%
Q2 2022$1,208,000
-70.0%
335,689
-48.3%
0.00%
-100.0%
Q1 2022$4,032,000
-11.0%
649,325
+1.0%
0.00%0.0%
Q4 2021$4,532,000
+2.8%
642,900
+1.7%
0.00%0.0%
Q3 2021$4,410,000
-13.8%
631,888
+2.9%
0.00%0.0%
Q2 2021$5,114,000
+55.9%
613,963
+2.2%
0.00%0.0%
Q1 2021$3,281,000
+39.9%
601,039
+9.9%
0.00%
Q4 2020$2,345,000
+47.9%
546,714
+3.8%
0.00%
Q3 2020$1,586,000
-1.7%
526,952
+1.2%
0.00%
Q2 2020$1,613,000
+167.1%
520,650
+90.4%
0.00%
Q1 2020$604,000
-63.7%
273,499
-49.9%
0.00%
Q4 2019$1,664,000
+101.9%
545,686
+103.4%
0.00%
Q3 2019$824,000
+78.4%
268,231
+16.1%
0.00%
Q2 2019$462,000
-71.0%
231,130
-37.4%
0.00%
Q1 2019$1,591,000
-29.0%
369,328
-47.7%
0.00%
Q4 2018$2,242,000
+27.7%
705,650
+111.0%
0.00%
Q3 2018$1,755,000
+20.0%
334,453
+22.4%
0.00%
Q2 2018$1,462,000
+99.5%
273,283
+86.2%
0.00%
Q1 2018$733,000
+51.4%
146,7910.0%0.00%
Q4 2017$484,000
-12.0%
146,7910.0%0.00%
Q3 2017$550,000
+47.1%
146,7910.0%0.00%
Q2 2017$374,000
-5.6%
146,791
-3.8%
0.00%
Q1 2017$396,000
-11.0%
152,603
+4.6%
0.00%
Q4 2016$445,000
+12.7%
145,939
+0.4%
0.00%
Q3 2016$395,000
+5.3%
145,411
+10.7%
0.00%
Q2 2016$375,000
-26.3%
131,332
-22.1%
0.00%
Q1 2016$509,000
-11.8%
168,634
+1.4%
0.00%
Q4 2015$577,000
-8.0%
166,380
+0.2%
0.00%
Q3 2015$627,000
-26.8%
166,116
+10.4%
0.00%
Q2 2015$857,000
+7.4%
150,489
+9.6%
0.00%
Q1 2015$798,000
-17.3%
137,346
-19.4%
0.00%
-100.0%
Q4 2014$965,000
+38.1%
170,370
-0.5%
0.00%
Q3 2014$699,000
-6.4%
171,174
+4.2%
0.00%
Q2 2014$747,000
+26.4%
164,326
+31.6%
0.00%
Q1 2014$591,000
+39.1%
124,894
+38.1%
0.00%
Q4 2013$425,000
-8.8%
90,459
+2.1%
0.00%
Q3 2013$466,000
+16.2%
88,564
+4.4%
0.00%
Q2 2013$401,00084,8280.00%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Harvey Partners, LLC 790,000$2,378,0003.09%
Alambic Investment Management, L.P. 25,398$76,0000.83%
Adirondack Research & Management Inc. 190,494$573,0000.80%
Archon Capital Management LLC 881,794$2,654,0000.53%
BARD ASSOCIATES INC 1,483,610$4,465,0000.47%
DALTON GREINER HARTMAN MAHER & CO 909,977$2,739,0000.45%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 1,537,800$4,629,0000.40%
Portolan Capital Management 979,067$2,947,0000.33%
HEARTLAND ADVISORS INC 961,400$2,894,0000.25%
Granahan Investment Management 1,757,176$5,289,0000.18%
View complete list of HARVARD BIOSCIENCE INC shareholders